Media, PA, United States of America

Gregory R Ott

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 84(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2004 - 2006)
  • Media, PA (US) (2004 - 2021)
  • West Chester, PA (US) (2021 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: The Innovative Contributions of Gregory R. Ott in Cancer Research

Introduction: Gregory R. Ott, a prominent inventor based in Media, PA, has made significant contributions to the field of cancer research, amassing a remarkable portfolio of 25 patents. His innovative work focuses on developing therapeutic compounds that target critical pathways involved in cell division and proliferation.

Latest Patents: Among Gregory R. Ott's notable inventions are the pyrimidinone derivatives designed as CDC7 inhibitors. These compounds, outlined in his patents, serve as inhibitors of the cell division cycle 7 (Cdc7) kinase enzyme activity. The significance of this invention lies in its potential application as a treatment for proliferative disorders, including various forms of cancer. The pharmaceutical compositions derived from these compounds represent promising advancements in therapeutic options for diseases where Cdc7 kinase activity plays a pivotal role.

Career Highlights: Throughout his career, Gregory R. Ott has worked with esteemed organizations such as Cephalon, Inc. and Cancer Research Technology Limited. His tenure at these companies has not only honed his expertise in pharmaceutical innovation but also facilitated the development of groundbreaking treatments that can impact patients facing serious health challenges.

Collaborations: Gregory's career has also been marked by fruitful collaborations with accomplished colleagues like Bruce D. Dorsey and Henry Joseph Breslin. These partnerships underscore the importance of teamwork in research and development, ultimately leading to more effective and innovative solutions in medicine.

Conclusion: Gregory R. Ott’s work exemplifies the critical role of inventors in advancing therapeutic interventions. With his 25 patents, particularly in the realm of Cdc7 inhibitors, he continues to be a transformative figure in cancer treatment development, paving the way for future innovations that can improve patient outcomes in oncology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…